PT3665176T - Formas sólidas de 3-(5-fluorobenzofurano-3-il)-4-(5-metil-5h[1,3]dioxolo[4,5-f]indol-7-il)pirrol-2,5-diona - Google Patents
Formas sólidas de 3-(5-fluorobenzofurano-3-il)-4-(5-metil-5h[1,3]dioxolo[4,5-f]indol-7-il)pirrol-2,5-dionaInfo
- Publication number
- PT3665176T PT3665176T PT187601687T PT18760168T PT3665176T PT 3665176 T PT3665176 T PT 3665176T PT 187601687 T PT187601687 T PT 187601687T PT 18760168 T PT18760168 T PT 18760168T PT 3665176 T PT3665176 T PT 3665176T
- Authority
- PT
- Portugal
- Prior art keywords
- fluorobenzofuran
- dioxolo
- indol
- dione
- pyrrole
- Prior art date
Links
- FARXPFGGGGLENU-UHFFFAOYSA-N 3-(5-fluoro-1-benzofuran-3-yl)-4-(5-methyl-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione Chemical compound C12=CC=3OCOC=3C=C2N(C)C=C1C1=C(C=2C3=CC(F)=CC=C3OC=2)C(=O)NC1=O FARXPFGGGGLENU-UHFFFAOYSA-N 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762544277P | 2017-08-11 | 2017-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3665176T true PT3665176T (pt) | 2024-03-13 |
Family
ID=63405430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT187601687T PT3665176T (pt) | 2017-08-11 | 2018-08-10 | Formas sólidas de 3-(5-fluorobenzofurano-3-il)-4-(5-metil-5h[1,3]dioxolo[4,5-f]indol-7-il)pirrol-2,5-diona |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11136334B2 (pt) |
| EP (1) | EP3665176B1 (pt) |
| JP (2) | JP7424639B2 (pt) |
| KR (2) | KR20240063198A (pt) |
| CN (2) | CN111247153B (pt) |
| AU (2) | AU2018313259B2 (pt) |
| BR (1) | BR112020002892A2 (pt) |
| CA (1) | CA3072240A1 (pt) |
| DK (1) | DK3665176T3 (pt) |
| ES (1) | ES2974328T3 (pt) |
| FI (1) | FI3665176T3 (pt) |
| IL (2) | IL272556B1 (pt) |
| MX (3) | MX2020001547A (pt) |
| PL (1) | PL3665176T3 (pt) |
| PT (1) | PT3665176T (pt) |
| WO (1) | WO2019032958A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020003431A (es) | 2017-10-16 | 2020-07-29 | Actuate Therapeutics Inc | Formas solidas de 3-(5-fluorobenzofuran-3-il)-4-(5-metil-5h-[1,3]d ioxolo[4,5-f]indol-7-il)pirrol- 2,5-diona. |
| JP7471660B2 (ja) * | 2018-05-17 | 2024-04-22 | アクチュエイト セラピューティクス インク． | グリコーゲンシンターゼキナーゼ３型β阻害剤による特発性肺線維症の治療 |
| WO2024006750A1 (en) * | 2022-06-27 | 2024-01-04 | Actuate Therapeutics, Inc. | Oral dosage forms of elraglusib |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2446269T3 (es) | 2006-12-19 | 2014-03-06 | The Board Of Trustees Of The University Of Illinois | 3-Benzofuranil-4-indolil-maleimidas como potentes inhibidores de GSK-3 para trastornos neurodegenerativos |
| KR101669707B1 (ko) | 2009-12-23 | 2016-10-27 | 아르퀼 인코포레이티드 | 정제된 피롤로퀴놀리닐-피롤리딘-2,5-디온 조성물 및 이의 제조 방법 및 사용 방법 |
-
2018
- 2018-08-10 US US16/638,303 patent/US11136334B2/en active Active
- 2018-08-10 BR BR112020002892-4A patent/BR112020002892A2/pt unknown
- 2018-08-10 WO PCT/US2018/046203 patent/WO2019032958A1/en unknown
- 2018-08-10 CA CA3072240A patent/CA3072240A1/en active Pending
- 2018-08-10 CN CN201880059690.4A patent/CN111247153B/zh active Active
- 2018-08-10 CN CN202311213594.XA patent/CN117362305A/zh active Pending
- 2018-08-10 EP EP18760168.7A patent/EP3665176B1/en active Active
- 2018-08-10 IL IL272556A patent/IL272556B1/en unknown
- 2018-08-10 JP JP2020530441A patent/JP7424639B2/ja active Active
- 2018-08-10 FI FIEP18760168.7T patent/FI3665176T3/fi active
- 2018-08-10 ES ES18760168T patent/ES2974328T3/es active Active
- 2018-08-10 AU AU2018313259A patent/AU2018313259B2/en active Active
- 2018-08-10 PT PT187601687T patent/PT3665176T/pt unknown
- 2018-08-10 DK DK18760168.7T patent/DK3665176T3/da active
- 2018-08-10 IL IL313800A patent/IL313800A/en unknown
- 2018-08-10 MX MX2020001547A patent/MX2020001547A/es unknown
- 2018-08-10 KR KR1020247014386A patent/KR20240063198A/ko active Application Filing
- 2018-08-10 PL PL18760168.7T patent/PL3665176T3/pl unknown
- 2018-08-10 KR KR1020207006706A patent/KR102700883B1/ko active IP Right Grant
-
2020
- 2020-02-07 MX MX2023005875A patent/MX2023005875A/es unknown
- 2020-02-07 MX MX2024003249A patent/MX2024003249A/es unknown
-
2021
- 2021-09-24 US US17/484,025 patent/US20220009939A1/en active Pending
-
2023
- 2023-02-23 AU AU2023201059A patent/AU2023201059A1/en active Pending
- 2023-07-28 JP JP2023123302A patent/JP2023156372A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023201059A1 (en) | 2023-03-23 |
| FI3665176T3 (fi) | 2024-03-20 |
| PL3665176T3 (pl) | 2024-06-17 |
| EP3665176B1 (en) | 2024-01-24 |
| EP3665176A1 (en) | 2020-06-17 |
| KR20240063198A (ko) | 2024-05-09 |
| JP2023156372A (ja) | 2023-10-24 |
| CN111247153A (zh) | 2020-06-05 |
| MX2024003249A (es) | 2024-04-04 |
| MX2020001547A (es) | 2020-08-03 |
| BR112020002892A2 (pt) | 2020-08-04 |
| CA3072240A1 (en) | 2019-02-14 |
| MX2023005875A (es) | 2023-06-05 |
| WO2019032958A1 (en) | 2019-02-14 |
| JP7424639B2 (ja) | 2024-01-30 |
| AU2018313259B2 (en) | 2022-11-24 |
| IL272556A (en) | 2020-03-31 |
| US20200223861A1 (en) | 2020-07-16 |
| AU2018313259A1 (en) | 2020-02-27 |
| KR20200040799A (ko) | 2020-04-20 |
| IL272556B1 (en) | 2024-09-01 |
| JP2020530497A (ja) | 2020-10-22 |
| US11136334B2 (en) | 2021-10-05 |
| CN117362305A (zh) | 2024-01-09 |
| KR102700883B1 (ko) | 2024-09-02 |
| US20220009939A1 (en) | 2022-01-13 |
| ES2974328T3 (es) | 2024-06-26 |
| DK3665176T3 (da) | 2024-03-25 |
| IL313800A (en) | 2024-08-01 |
| CN111247153B (zh) | 2024-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272748A (en) | 3-(1-Oxoisoindolin-2-YL)piperidine-2,6-dione derivatives and their use | |
| IL288104A (en) | Heterocyclic compounds, preparation methods and their use | |
| IL272556A (en) | Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H[3,1]dioxo[5,4-F]indol-7-yl)pyrrol-5,2-dione | |
| PH12020500371A1 (en) | Spirocycle compounds and methods of making and using same | |
| PH12020500372A1 (en) | Spirocycle compounds and methods of making and using same | |
| IL260495B (en) | History of 3-(carboxyethyl)-8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
| DK3402785T3 (da) | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater | |
| IL273920A (en) | Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[3,1]dioxolo[5,4-F]indol-7-yl)pyrrol-5,2-dione | |
| EP3691564A4 (en) | REMOVABLE DENTAL DEVICE WITH BRIDGES | |
| EP3461828A3 (en) | Methods of preparing toll-like receptor modulators | |
| EP3233088A4 (en) | Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof | |
| EP3656346A4 (en) | DENTAL IMPLANT | |
| EP3645008A4 (en) | SUBSTITUTED QUINOLINYCYCLOHEXYLPROPANAMIDE COMPOUNDS AND IMPROVED METHODS FOR THEIR PRODUCTION | |
| EP3807247A4 (en) | PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS AND PROCESSES | |
| EP3806814A4 (en) | PHOTO STABILIZATION COMPOUNDS, COMPOSITIONS, AND PROCEDURES | |
| EP3654906A4 (en) | PRP PREPARATION PROCESS, DEVICE AND KIT | |
| EP3574866A4 (en) | DENTAL IMPLANT | |
| EP3807275A4 (en) | PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS AND PROCESSES | |
| EP3806815A4 (en) | PHOTOSTABILIZING COMPOUNDS, COMPOSITIONS, AND PROCEDURES | |
| AU2018903949A0 (en) | Cyclic Compounds as Receptor Modulating Therapeutics and Methods and Uses Thereof | |
| AU2018903789A0 (en) | Content modification | |
| UA106811U (uk) | 3-(4-ХЛОРОБЕНЗИЛІДЕН)-3Н-ТІАЗОЛО[4,3-b]ХІНАЗОЛІН-1,9-ДІОН, ЩО ПРОЯВЛЯЄ АНТИЕКСУДАТИВНУ ДІЮ |